Updates are available Correction dated 2023-11-23
Click to view Correction: https://doi.org/10.1038/s41593-023-01531-0
-
Authors
Frazel, Paul W. https://orcid.org/0000-0002-6967-8616
Labib, David https://orcid.org/0000-0002-9344-9856
Fisher, Theodore
Brosh, Ran https://orcid.org/0000-0001-9714-8623
Pirjanian, Nicolette
Marchildon, Anne
Boeke, Jef D. https://orcid.org/0000-0001-5322-4946
Fossati, Valentina https://orcid.org/0000-0003-1825-9371
Liddelow, Shane A. https://orcid.org/0000-0002-0840-1437
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY033353, R01EY033353, R01EY033353, R01EY033353, R01EY033353, R01EY033353, R01EY033353, R01EY033353, R01EY033353)
- License Information
-
More Information
Article History
Received: 12 August 2022
Accepted: 8 August 2023
First Online: 11 September 2023
Change Date: 23 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41593-023-01531-0
Competing interests
: S.A.L. is an academic founder and sits on the SAB of AstronauTx Ltd. and is a SAB member of the BioAccess Fund. J.D.B. is a founder and director of CDI Labs Inc., a founder of and consultant to Neochromosome Inc., a founder member of SAB, a consultant to ReOpen Diagnostics LLC and serves or served on the SAB of the following: Logomix, Inc., Sangamo Inc., Modern Meadow Inc., Rome Therapeutics Inc., Sample6 Inc., Tessera Therapeutics Inc. and the Wyss Institute. The remaining authors declare no competing interests. V.F. is listed as inventor on issued and pending patent claims covering glial cell generation methods.
